The automated analyzers market covers equipment and devices that are used to perform clinical tests in laboratories without any human intervention. Automated analyzers greatly reduce manual intervention and errors by automating the sample handling and processing.They are used to analyze biological samples like blood, urine, and tissue in clinical laboratories for diagnostic testing. The adoption of automated analyzers helps in improving workflow efficiency, reduce turnaround times, increase productivity and handle a high volume of samples. The increasing complexity of medical testing and focus on delivering faster diagnostics is driving the need for automated, high-throughput equipment in clinical laboratories. This has significantly boosted the demand for advanced automated analyzers globally.

The Global automated analyzers market is estimated to be valued at US$ 5.56 Bn in 2024 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the automated analyzers market are Abbott, Danaher, Thermo Fisher Scientific, Inc., Becton, Agilent Technologies, Inc., Zimed Healthcare Inc., Biobase Biodusty(Shandong), Co., Ltd., Chongqing Drawell Instrument CO,.Ltd, Transasia Bio-Medicals, Awareness Technology, Inc., Trivitron Healthcare, Getein Biotech, Inc., Eppendorf AG, Honeywell International, Inc., Aurora Biomed, HORIBA, Ltd., Beckman Coulter, Inc. These players are focusing on new product launches and expanding their presence globally to strengthen their Automated Analyzers Market Size position.

The growing demand for clinical diagnostic testing, increasing prevalence of chronic and infectious diseases, and rising geriatric population are expected to offer significant growth opportunities for players in the automated analyzers market. Major players are focusing their efforts on emerging markets in Asia Pacific and Latin America which are expected to witness high demand owing to improving healthcare infrastructure and increasing medical spending in these regions.

Abbott and Thermo Fisher Scientific have expanded their global footprint through acquisitions to gain access to new technologies and additional markets. Other players are also focusing on strategic collaborations and agreements with regional diagnostic players and laboratories to increase penetration in international markets.

Market Drivers

Growing prevalence of chronic and infectious diseases is significantly boosting the demand for clinical diagnostic testing globally. According to the World Health Organization, chronic diseases are estimated to account for nearly 60% of all deaths worldwide. This high disease burden has increased the need for faster test result delivery using automated high-throughput analyzers.

Market Restrains

High costs associated with automated analyzers and their maintenance is a major challenge, especially for small- and medium-sized clinical laboratories in developing regions. The lack of skilled technicians to operate sophisticated automated systems in these settings also hampers market growth. Additionally, stringent regulatory approval processes and quality standards for these systems increase compliance burden on market players.

Segment Analysis

The automated analyzers market can be segmented into clinical and point-of-care analyzers. Clinical analyzers dominated more than 50% of the market share in 2024 due to their widespread adoption in hospitals and diagnostics labs for high volume sample testing. Clinical analyzers offer faster turnaround time, accuracy, and reliability for analyzing liquid samples like blood and urine. Point-of-care analyzers are gaining popularity due to growing need for near patient testing and quick diagnostic results. This segment is expected to witness higher growth during the forecast period.

Global Analysis

Regionally, North America held the largest share of the automated analyzers market in 2024 owing to presence of major players, increasing geriatric population and rising cases of chronic diseases. The growth in this region can be attributed to growing demand from clinical laboratories and hospitals for timely diagnostic test results. Europe captured the second largest market share due to favorable reimbursements for clinical tests and rising healthcare spending. Asia Pacific is expected to witness fastest growth during the forecast period supported by improving healthcare infrastructure, growing medical tourism, and increasing awareness regarding disease diagnosis in countries like India, China and Japan. Rising government initiatives for modernizing healthcare facilities are fueling adoption of automated platforms in developing nations of Latin America and Middle-East & Africa.

Get More Insights On- Automated Analyzers Market Size